Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01- Basic Experimental Studies with Humans) (PAR-21-280)

GRANT Friday, July 9, 2021- 17:15 National Institutes of Health Multiple dates, see announcement. Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01- Basic Experimental Studies with Humans) (PAR-21-280)

Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) (PAR-21-281)

GRANT Friday, July 9, 2021- 17:15 National Institutes of Health Multiple dates, see announcement. Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trials Not Allowed) (PAR-21-281)

Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) (RFA-AG-22-022)

GRANT Friday, July 9, 2021- 17:15 National Institute on Aging NIA intends to commit $750,000 in FY 2022 to fund four awards. October 28, 2021 Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional He

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) (RFA-AG-22-027)

GRANT Friday, July 9, 2021- 17:15 National Institute on Aging NIA intends to commit a total of $2.4 million in FY 2022 to fund approximately 15 awards. November 2, 2021 Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR)

PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-21-259)

GRANT Friday, July 9, 2021- 17:00 National Institutes of Health Standard dates apply. PHS 2021-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) (PA-21-259

Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome Across the Lifespan (R21 Clinical Trial Not Allowed) (NOT-OD-21-092)

GRANT Friday, July 2, 2021- 14:45 National Institutes of Health Use of Digital Technology and Mobile Health (mHealth) to Improve Diagnosis, Assessments, Interventions, Management and Outcomes for Individuals with Down Syndrome

Notice of Special Interest: Alzheimers-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimers Disease (NOT-AG-21-018)

GRANT Sunday, June 27, 2021- 11:15 National Institutes of Heath Individual requests can be no more than $250,000 in direct costs exclusive of Facilities and Administrative costs on subcontracts. October 1, 2021, by 5 p.m. local time of applicant organization. N

Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including AD/ADRD) (R01 Clinical Trial Not Allowed) (RFA-AG-22-025)

GRANT Sunday, June 27, 2021- 11:00 National Institute on Aging NIA intends to commit $3 million in FY 2022 to fund up to two awards. October 20, 2021 Data Enhancements and Analyses to Clarify the Relationship between Education and Cognitive Function (including

Role of Adaptive Immunity in Etiology of Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Optional)

GRANT Friday, June 18, 2021- 10:30 National Institutes of Health The National Institute on Aging intends to commit $8 million in FY 2022 to fund 10-12 awards. September 28, 2021 Role of Adaptive Immunity in Etiology of Alzheimer’s Disease and Alzheimer’s Diseas

Microbial Pathogenesis in Alzheimer’s Disease Grant

GRANT Wednesday, June 16, 2021- 18:15 Infectious Diseases Society of America Foundation $1.7 million, with individuals grants ranging between $30,000-$250,000 August 31, 2021 Microbial Pathogenesis in Alzheimer’s Disease Grant

BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (RFA-NS-21-026)

GRANT Saturday, June 12, 2021- 19:00 National Institutes of Health Issuing IC and partner components intend to commit an estimated total of $10 million per year to fund 15-20 awards. Multiple dates, see announcement. BRAIN Initiative: New Technologies and Novel

High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) (RFA-AG-22-019)

GRANT Saturday, June 12, 2021- 19:00 National Institute on Aging NIA intends to commit $4.8 million in FY 2022 to fund six to eight awards. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious appli

NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) (RFA-AG-22-014)

GRANT Saturday, June 12, 2021- 19:00 National Institute on Aging NIA intends to commit $1.5 million in FY 2022 to fund four awards. October 26, 2021 NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (

NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) (RFA-AG-22-007)

GRANT Saturday, June 12, 2021- 19:00 National Institute on Aging NIA intends to commit $1.5 million in FY 2022 to fund four awards. October 26, 2021 NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (

NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) (RFA-AG-22-004)

GRANT Saturday, June 12, 2021- 19:00 National Institute on Aging September 29, 2021 NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) (RFA-AG-22-004)